Femasys Inc. $FEMY Announces First Patient Treated in Pivotal Trial for FemaSeed

*First in Class Insemination Treatment for Infertility*

*LOCAL Pivotal Trial to Enroll Up to 792 Patients Across 20 U.S. Centers*

ATLANTA, July 20, 2021 (GLOBE NEWSWIRE) — Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on transforming women’s healthcare, today announced the initiation and first patient treated in a pivotal trial evaluating FemaSeed, a first in class, localized directional insemination product candidate for infertility. [https://finance.yahoo.com/news/femasys-inc-announces-first-patient-123100881.html?soc\_src=social-sh&soc\_trk=tw&tsrc=twtr](https://finance.yahoo.com/news/femasys-inc-announces-first-patient-123100881.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr)
https://www.reddit.com/r/StockMarket/comments/oo1kr5/femasys_inc_femy_announces_first_patient_treated/